Body Pharm - MOTS-C 32mg | Pre-Filled Pen

Body Pharm MOTS-C 32mg Pre-Filled Pen

Body Pharm MOTS-C 32mg Pre-Filled Pen contains 32 mg of MOTS-C, a mitochondrial-derived peptide that has been researched for its potential role in cellular energy regulation, glucose metabolism, metabolic flexibility, and mitochondrial function.

MOTS-C is naturally encoded within mitochondrial DNA and is thought to function as a signalling molecule that helps cells respond and adapt to metabolic stress.

Research into MOTS-C has focused on its potential effects on insulin sensitivity, glucose utilisation, energy metabolism, physical performance, and healthy ageing. However, much of the current evidence remains preclinical, and MOTS-C is still considered an investigational peptide.

The pre-filled pen provides a convenient format for subcutaneous administration without requiring manual peptide reconstitution.

What BP MOTS-C 32mg Is Used For

MOTS-C is primarily researched for its potential role in:

• Supporting cellular and mitochondrial energy metabolism
• Improving metabolic flexibility
• Supporting glucose utilisation
• Supporting insulin sensitivity
• Influencing fat and carbohydrate metabolism
• Supporting physical endurance and exercise capacity
• Supporting recovery from metabolic and physical stress
• Promoting healthy mitochondrial function
• Supporting metabolic health and healthy-ageing research

MOTS-C has attracted particular research interest because mitochondrial function is closely associated with energy production, metabolic health, physical performance, and ageing.

It is important to note that MOTS-C is not an approved treatment for weight loss, diabetes, insulin resistance, or anti-ageing purposes.

How BP MOTS-C 32mg Works

MOTS-C acts as a mitochondrial-derived signalling peptide involved in communication between the mitochondria and other parts of the cell.

Research suggests that MOTS-C may influence pathways responsible for how cells produce and utilise energy.

Its proposed mechanisms include:

• Supporting cellular glucose uptake and utilisation
• Influencing pathways involved in insulin sensitivity
• Supporting mitochondrial energy regulation
• Activating cellular pathways involved in metabolic adaptation
• Supporting the body's response to metabolic stress
• Influencing fat and carbohydrate utilisation
• Supporting metabolic flexibility — the ability to efficiently switch between different energy sources

Research has particularly investigated the relationship between MOTS-C and AMP-activated protein kinase (AMPK), an important cellular energy-sensing pathway involved in glucose and lipid metabolism.

How to Use BP MOTS-C 32mg

Use this product only as directed by a healthcare professional or supervising practitioner.

Administration Route: Subcutaneous injection using the pre-filled pen.

Dosage Information

Body Pharm MOTS-C Pre-Filled Pen contains a total of:

• 32 mg MOTS-C

There is currently no universally established or regulator-approved human dosing regimen for MOTS-C.

The supplied Body Pharm information describes protocols involving administration several times per week and use over approximately 4–6 weeks. However, these represent non-standardized peptide protocols rather than an established clinical dosing schedule.

The appropriate pen setting, dose, injection frequency, and duration should therefore be determined with appropriate professional guidance.

Possible Side Effects

Human safety information for MOTS-C remains limited, and a comprehensive adverse-effect profile has not yet been established.

Common

Potential or anticipated effects associated with injectable peptide administration may include:

• Injection-site redness or irritation
• Mild tenderness at the injection site
• Headache
• Temporary fatigue
• Nausea
• Changes in energy levels